Padma-Nathan Harin 4
4 · NURX PHARMACEUTICALS, INC. · Filed Nov 12, 2009
Insider Transaction Report
Form 4
Padma-Nathan Harin
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2009-10-29+500,000→ 500,000 totalExercise: $0.45Exp: 2014-10-29→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]The option will vest and become exercisable in installments over a period of three years.